77 related articles for article (PubMed ID: 29447632)
1. Greater distance to an academic medical center is associated with poorer melanoma prognostic factors: The University of Colorado Experience.
Snyder BM; Mounessa JS; Fazzari M; Caravaglio JV; Kretowicz A; Braunberger T; Wells K; Dunnick CA; Dellavalle RP; Alkousakis T
Dermatol Online J; 2017 Nov; 23(11):. PubMed ID: 29447632
[TBL] [Abstract][Full Text] [Related]
2. Gender differences in melanoma prognostic factors.
Farahi JM; Fazzari M; Braunberger T; Caravaglio JV; Kretowicz A; Wells K; Dellavalle RP; Norris D; Alkousakis T
Dermatol Online J; 2018 Apr; 24(4):. PubMed ID: 29905998
[TBL] [Abstract][Full Text] [Related]
3. Distance to diagnosing provider as a measure of access for patients with melanoma.
Stitzenberg KB; Thomas NE; Dalton K; Brier SE; Ollila DW; Berwick M; Mattingly D; Millikan RC
Arch Dermatol; 2007 Aug; 143(8):991-8. PubMed ID: 17709657
[TBL] [Abstract][Full Text] [Related]
4. Symptoms and signs of primary melanoma: important indicators of Breslow depth.
Negin BP; Riedel E; Oliveria SA; Berwick M; Coit DG; Brady MS
Cancer; 2003 Jul; 98(2):344-8. PubMed ID: 12872355
[TBL] [Abstract][Full Text] [Related]
5. Distance as a Barrier to Melanoma Care.
McCarthy S; Feeley K; Murphy M; Bourke JF
Ir Med J; 2019 Aug; 112(7):974. PubMed ID: 31642656
[TBL] [Abstract][Full Text] [Related]
6. Identification of higher risk thin melanomas should be based on Breslow depth not Clark level IV.
Owen SA; Sanders LL; Edwards LJ; Seigler HF; Tyler DS; Grichnik JM
Cancer; 2001 Mar; 91(5):983-91. PubMed ID: 11251950
[TBL] [Abstract][Full Text] [Related]
7. Domestic Travel and Regional Migration for Parathyroid Surgery Among Patients Receiving Care at Academic Medical Centers in the United States, 2012-2014.
Hinson AM; Hohmann SF; Stack BC
JAMA Otolaryngol Head Neck Surg; 2016 Jul; 142(7):641-7. PubMed ID: 27124618
[TBL] [Abstract][Full Text] [Related]
8. Impact of travel distance to the treatment facility on overall mortality in US patients with prostate cancer.
Vetterlein MW; Löppenberg B; Karabon P; Dalela D; Jindal T; Sood A; Chun FK; Trinh QD; Menon M; Abdollah F
Cancer; 2017 Sep; 123(17):3241-3252. PubMed ID: 28472547
[TBL] [Abstract][Full Text] [Related]
9. [Sentinel lymph node biopsy in patients with melanoma].
Tomás-Mallebrera L; Rojo-España R; Marquina-Vila A; Gimeno-Clemente N; Morales-Suárez-Varela MM
Actas Dermosifiliogr; 2010 Jun; 101(5):428-36. PubMed ID: 20525486
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of melanoma features and their relationship with nodal disease: the importance of the pathological report.
Bertolli E; de Macedo MP; Pinto CA; Damascena AS; Molina AS; Ueno PS; Duprat Neto JP
Tumori; 2015; 101(5):501-5. PubMed ID: 25983100
[TBL] [Abstract][Full Text] [Related]
11. Prognostic value of sentinel node biopsy in 327 prospective melanoma patients from a single institution.
Roulin D; Matter M; Bady P; Liénard D; Gugerli O; Boubaker A; Bron L; Lejeune FJ
Eur J Surg Oncol; 2008 Jun; 34(6):673-9. PubMed ID: 17825518
[TBL] [Abstract][Full Text] [Related]
12. A retrospective, multicenter analysis of the predictive value of mitotic rate for sentinel lymph node (SLN) positivity in thin melanomas.
Wat H; Senthilselvan A; Salopek TG
J Am Acad Dermatol; 2016 Jan; 74(1):94-101. PubMed ID: 26542815
[TBL] [Abstract][Full Text] [Related]
13. The impact of factors beyond Breslow depth on predicting sentinel lymph node positivity in melanoma.
Paek SC; Griffith KA; Johnson TM; Sondak VK; Wong SL; Chang AE; Cimmino VM; Lowe L; Bradford CR; Rees RS; Sabel MS
Cancer; 2007 Jan; 109(1):100-8. PubMed ID: 17146784
[TBL] [Abstract][Full Text] [Related]
14. A retrospective comparison between preoperative and postoperative Breslow depth in primary cutaneous melanoma: how preoperative shave biopsies affect surgical management.
Saco M; Thigpen J
J Drugs Dermatol; 2014 May; 13(5):531-6. PubMed ID: 24809875
[TBL] [Abstract][Full Text] [Related]
15. The effect of distance traveled on disease outcomes in gestational trophoblastic neoplasia.
Clark LH; Staley SA; Barber EL; Wysham WZ; Kim KH; Soper JT
Am J Obstet Gynecol; 2016 Aug; 215(2):217.e1-5. PubMed ID: 26875944
[TBL] [Abstract][Full Text] [Related]
16. Prognostic factors in young women with cutaneous melanoma.
Burton AL; Egger ME; Quillo AR; Stromberg AJ; Hagendoorn L; Scoggins CR; Martin RC; McMasters KM; Callender GG
Am J Surg; 2014 Jan; 207(1):102-8. PubMed ID: 24330977
[TBL] [Abstract][Full Text] [Related]
17. Sentinel lymph node biopsy for cutaneous melanoma: the Stanford experience, 1997-2004.
Berk DR; Johnson DL; Uzieblo A; Kiernan M; Swetter SM
Arch Dermatol; 2005 Aug; 141(8):1016-22. PubMed ID: 16103331
[TBL] [Abstract][Full Text] [Related]
18. Sentinel Lymph Node Biopsy Provides Prognostic Value in Thick Head and Neck Melanoma.
Monroe MM; Pattisapu P; Myers JN; Kupferman ME
Otolaryngol Head Neck Surg; 2015 Sep; 153(3):372-8. PubMed ID: 26070510
[TBL] [Abstract][Full Text] [Related]
19. Clinicopathologic study of 85 cases of melanoma of the female genitalia.
Tcheung WJ; Selim MA; Herndon JE; Abernethy AP; Nelson KC
J Am Acad Dermatol; 2012 Oct; 67(4):598-605. PubMed ID: 22243767
[TBL] [Abstract][Full Text] [Related]
20. [Important prognostic significance of a sentinel-node biopsy in patients with malignant melanoma].
Keijzer R; Bril H; van der Loo EM; de Graaf PW
Ned Tijdschr Geneeskd; 2004 May; 148(18):884-8. PubMed ID: 15152391
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]